CLINICAL_TRIALS
trial_result
· 2020-08-10
Clinical Trial Update: Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis [Phase 4]
Summary
Phase 4 trial evaluating the impact of sarilumab on patient-reported outcomes in active rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2020-08-10